As­traZeneca pre­pares to live with the IRA, shift­ing fo­cus of ar­gu­ments to or­phan drug changes

NEW YORK — As­traZeneca may be get­ting ready to live with the In­fla­tion Re­duc­tion Act.

On Fri­day morn­ing, CEO Pas­cal So­ri­ot told re­porters that the drug­mak­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER